Update on Hair Replacement Therapy

    Kenneth A. Buchwach
    Image of study
    TLDR Hair transplantation, especially follicular unit micrografting, was the top treatment for male pattern baldness, with a focus on natural results and ongoing improvements in both surgical and medical management.
    In 2002, hair transplantation, particularly follicular unit micrografting, was the leading treatment for male pattern baldness, which affected over 30 million men and an increasing number of women. This technique, which transplants hair in its natural groupings, had become the most popular due to its natural-looking results. The document also discussed the importance of careful planning and technique in hair restoration to account for the progressive nature of baldness and to minimize scarring. It covered the debate over achieving naturalness and density, with some surgeons combining follicular units and minigrafts. Studies suggested that CO₂ lasers caused less thermal damage and that a combination of low-power CO₂ and Erbium:YAG lasers was optimal. The angle of recipient site placement and hairline design were crucial for a natural appearance, and eyebrow reconstruction was also addressed. Medical treatments like Minoxidil and Finasteride were noted to be better at preserving hair than regrowing it. The document concluded that while surgical hair replacement was being refined, there was a need for better medical management of hair loss in both men and women.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results

      community Verteporfin and Microneedling

      in Treatments 4 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Hair Cloning, Trials were supposed to begin 2020-2021

      in Technology  48 upvotes 4 years ago
      The conversation discusses hair cloning trials expected to start in 2020-2021 and mentions concerns about potential delays due to the Coronavirus. Treatments like Minoxidil, finasteride, and RU58841 are referenced.

      community How is verteporfin doing in trials?

      in Chat  9 upvotes 11 months ago
      The conversation is about the progress of verteporfin in hair loss trials, with users expressing curiosity about its effectiveness and updates. Specific treatments mentioned include FUE (Follicular Unit Extraction) combined with verteporfin, with one reported case of donor area regrowth after a year, and three patients being monitored post-treatment by Dr. Bloxham with monthly updates on YouTube.

    Related Research

    3 / 3 results